SIRT1 and cancer: Indeed, the use of NAM as an inhibitor of both Sirt1 and poly-ADP-ribose polymerases has been proposed for cancer chemoprevention and therapy, especially in those malignancies where NNMT has been reported to be upregulated [66,67,68].